Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Varian, a Siemens Healthineers Company
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Indiana University
AgonOx, Inc.
British Columbia Cancer Agency
Dana-Farber Cancer Institute
Milton S. Hershey Medical Center
Marengo Therapeutics, Inc.
University of California, Irvine
Stanford University
Mayo Clinic
Massachusetts General Hospital
Mayo Clinic
Sheba Medical Center
National Institutes of Health Clinical Center (CC)
Virginia Commonwealth University
IGF Oncology, LLC
sigma-tau i.f.r. S.p.A.
University of Toronto
Region Skane
Sir Mortimer B. Davis - Jewish General Hospital
British Columbia Cancer Agency
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Pharmacyclics LLC.